IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 77 filers reported holding IGM BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,649 | -91.0% | 437 | -90.0% | 0.00% | – |
Q2 2023 | $40,446 | +216.2% | 4,382 | +370.7% | 0.00% | – |
Q1 2023 | $12,792 | +8.2% | 931 | +34.0% | 0.00% | – |
Q4 2022 | $11,822 | -30.5% | 695 | -6.2% | 0.00% | – |
Q3 2022 | $17,000 | -26.1% | 741 | -43.7% | 0.00% | – |
Q2 2022 | $23,000 | -68.1% | 1,315 | -51.2% | 0.00% | – |
Q1 2022 | $72,000 | -94.5% | 2,694 | -93.9% | 0.00% | -100.0% |
Q4 2021 | $1,301,000 | -2.7% | 44,362 | +118.3% | 0.00% | 0.0% |
Q3 2021 | $1,337,000 | -60.4% | 20,325 | -49.9% | 0.00% | -50.0% |
Q2 2021 | $3,377,000 | -6.5% | 40,592 | -13.8% | 0.00% | 0.0% |
Q1 2021 | $3,612,000 | +953.1% | 47,104 | +1110.3% | 0.00% | – |
Q4 2020 | $343,000 | +757.5% | 3,892 | +623.4% | 0.00% | – |
Q3 2020 | $40,000 | -89.7% | 538 | -89.9% | 0.00% | – |
Q2 2020 | $388,000 | +367.5% | 5,319 | +259.4% | 0.00% | – |
Q1 2020 | $83,000 | +118.4% | 1,480 | +48.9% | 0.00% | – |
Q4 2019 | $38,000 | – | 994 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |